Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease
Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
A phase II double blind trial to evaluate the effects of the AMPA, glutamte antagonist,
topiramate on levodopa-induced dyskinesia in Parkinson's disease